Thus, it will be important for future work to determine the predictive value of stromal TGFβR2 in prostate cancer, and to delineate the molecular mechanisms underpinning tumor progression in the context of TGFβR2 stromal loss. This evidence concerns the gene TGFBR2 and Familial prostate cancer.